Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Genomic profiling of renal cell carcinoma in patients with end-stage renal disease.

Inoue T, Matsuura K, Yoshimoto T, Nguyen LT, Tsukamoto Y, Nakada C, Hijiya N, Narimatsu T, Nomura T, Sato F, Nagashima Y, Kashima K, Hatakeyama S, Ohyama C, Numakura K, Habuchi T, Nakagawa M, Seto M, Mimata H, Moriyama M.

Cancer Sci. 2012 Mar;103(3):569-76. doi: 10.1111/j.1349-7006.2011.02176.x. Epub 2012 Jan 20.

2.

Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB.

Am J Surg Pathol. 2006 Feb;30(2):141-53.

PMID:
16434887
3.

Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.

Maruschke M, Reuter D, Koczan D, Hakenberg OW, Thiesen HJ.

BJU Int. 2011 Jul;108(2 Pt 2):E29-35. doi: 10.1111/j.1464-410X.2010.09794.x. Epub 2011 Mar 16.

4.

[Von-Hippel-Lindau gene mutation types. Association of gene expression signatures in clear cell renal cell carcinoma].

Luu VD, Fischer B, von Teichman A, Boysen G, Mertz K, Zimmermann P, Moch H, Schraml P.

Pathologe. 2008 Nov;29 Suppl 2:303-7. doi: 10.1007/s00292-008-1031-1. German.

PMID:
18751980
5.

Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.

Nouh MA, Kuroda N, Yamashita M, Hayashida Y, Yano T, Minakuchi J, Taniguchi S, Nomura I, Inui M, Sugimoto M, Kakehi Y.

BJU Int. 2010 Mar;105(5):620-7. doi: 10.1111/j.1464-410X.2009.08817.x. Epub 2009 Aug 28.

6.

Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.

Zhou M, Yang XJ, Lopez JI, Shah RB, Hes O, Shen SS, Li R, Yang Y, Lin F, Elson P, Sercia L, Magi-Galluzzi C, Tubbs R.

Am J Surg Pathol. 2009 Dec;33(12):1840-9. doi: 10.1097/PAS.0b013e3181be22d1.

PMID:
19898225
7.

Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.

Kroeze SG, Bijenhof AM, Bosch JL, Jans JJ.

Cancer Biomark. 2010;7(6):261-8. doi: 10.3233/CBM-2010-0195. Review.

PMID:
21694464
8.

Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.

Wang KL, Weinrach DM, Luan C, Han M, Lin F, Teh BT, Yang XJ.

Hum Pathol. 2007 Feb;38(2):239-46. Epub 2006 Oct 23.

PMID:
17056094
9.
10.

Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.

Waldert M, Haitel A, Marberger M, Katzenbeisser D, Ozsoy M, Stadler E, Remzi M.

BJU Int. 2008 Nov;102(10):1381-4. doi: 10.1111/j.1464-410X.2008.07999.x. Epub 2008 Sep 8.

11.

MicroRNA profiles classify papillary renal cell carcinoma subtypes.

Wach S, Nolte E, Theil A, Stöhr C, T Rau T, Hartmann A, Ekici A, Keck B, Taubert H, Wullich B.

Br J Cancer. 2013 Aug 6;109(3):714-22. doi: 10.1038/bjc.2013.313. Epub 2013 Jun 25.

12.

Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: cytogenetic and molecular genetic findings.

Hughson MD, Meloni AM, Silva FG, Sandberg AA.

Cancer Genet Cytogenet. 1996 Jul 1;89(1):65-8.

PMID:
8689614
13.

Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.

Gobbo S, Eble JN, Grignon DJ, Martignoni G, MacLennan GT, Shah RB, Zhang S, Brunelli M, Cheng L.

Am J Surg Pathol. 2008 Aug;32(8):1239-45. doi: 10.1097/PAS.0b013e318164bcbb.

PMID:
18594469
14.

MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array.

Albiges L, Guegan J, Le Formal A, Verkarre V, Rioux-Leclercq N, Sibony M, Bernhard JC, Camparo P, Merabet Z, Molinie V, Allory Y, Orear C, Couvé S, Gad S, Patard JJ, Escudier B.

Clin Cancer Res. 2014 Jul 1;20(13):3411-21. doi: 10.1158/1078-0432.CCR-13-2173. Epub 2014 Mar 21.

15.

Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.

Aron M, Chang E, Herrera L, Hes O, Hirsch MS, Comperat E, Camparo P, Rao P, Picken M, Michal M, Montironi R, Tamboli P, Monzon F, Amin MB.

Am J Surg Pathol. 2015 Jul;39(7):873-88. doi: 10.1097/PAS.0000000000000446.

PMID:
25970682
16.

The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.

Faragalla H, Youssef YM, Scorilas A, Khalil B, White NM, Mejia-Guerrero S, Khella H, Jewett MA, Evans A, Lichner Z, Bjarnason G, Sugar L, Attalah MI, Yousef GM.

J Mol Diagn. 2012 Jul;14(4):385-92. doi: 10.1016/j.jmoldx.2012.02.003. Epub 2012 May 9.

PMID:
22580180
17.

Strength of molecular cytogenetic analyses for adjusting the diagnosis of renal cell carcinomas with both clear cells and papillary features: a study of three cases.

Haudebourg J, Hoch B, Fabas T, Cardot-Leccia N, Burel-Vandenbos F, Vieillefond A, Amiel J, Michiels JF, Pedeutour F.

Virchows Arch. 2010 Sep;457(3):397-404. doi: 10.1007/s00428-010-0937-1. Epub 2010 Jun 22.

PMID:
20567845
18.

Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.

Lv D, Zhao W, Dong D, Qian XP, Zhang Y, Tian XJ, Zhang J.

Eur J Cancer. 2011 Sep;47(13):2068-76. doi: 10.1016/j.ejca.2011.04.021. Epub 2011 May 18.

PMID:
21600761
19.

Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.

Marsaud A, Dadone B, Ambrosetti D, Baudoin C, Chamorey E, Rouleau E, Lefol C, Roussel JF, Fabas T, Cristofari G, Carpentier X, Michiels JF, Amiel J, Pedeutour F.

Genes Chromosomes Cancer. 2015 Jun;54(6):369-82. doi: 10.1002/gcc.22248. Epub 2015 Mar 28.

PMID:
25820192
20.

Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma.

Pan CC, Chen YJ, Chang LC, Chang YH, Ho DM.

Histopathology. 2009 Aug;55(2):145-53. doi: 10.1111/j.1365-2559.2009.03361.x.

PMID:
19694821

Supplemental Content

Support Center